In focus · trending topic

pneumonia

17 stories · following the connections

Cempra Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update

By Nasdaq OMXFeb 24, 2016, 9:05 PM UTC

The Lancet Infectious Diseases Publishes Positive Phase 3 Study Results for Cempra’s Oral Solithromycin in Community-Acquired Bacterial Pneumonia

By Nasdaq OMXFeb 5, 2016, 12:00 PM UTC

Cempra to Present at the Leerink Partners 5th Annual Global Healthcare Conference

By Nasdaq OMXFeb 3, 2016, 12:30 PM UTC

Cempra and Macrolide Pharmaceuticals Enter Synthetic Manufacturing Process Development Agreement for Solithromycin

By Nasdaq OMXFeb 1, 2016, 12:30 PM UTC

Cempra to Ring NASDAQ Closing Bell to Mark 10th Anniversary

By Nasdaq OMXJan 26, 2016, 1:00 PM UTC

Cempra Completes Public Offering of Common Stock

By Nasdaq OMXJan 12, 2016, 9:05 PM UTC

Cempra Prices Public Offering of Common Stock

By Nasdaq OMXJan 7, 2016, 1:43 AM UTC

Melinta Therapeutics Initiates Phase 3 Study of Baxdela in Hospital-Treated Community-Acquired Bacterial Pneumonia

By Nasdaq OMXJan 6, 2016, 1:00 PM UTC